Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 53 entries
View as:

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044

Phase: N/A Priority: Normal
NCT ID: NCT04269707 Org: User:
Start: 11/19/19 End: 01/29/21 Due: 01/29/22

Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin

Phase: N/A Priority: Normal
NCT ID: NCT00239616 Org: User:
Start: 06/05/02 End: 09/15/03 Due: 09/15/04

Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT01382901 Org: User:
Start: 03/31/06 End: 07/31/07 Due: 07/31/08

Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT02409459 Org: User:
Start: 03/31/15 End: 03/31/16 Due: 03/31/17

Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01365624 Org: User:
Start: 02/29/08 End: 07/31/08 Due: 07/31/09

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00236977 Org: User:
Start: 08/31/03 End: 10/31/04 Due: 10/31/05

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

Phase: N/A Priority: Normal
NCT ID: NCT02453334 Org: User:
Start: 05/23/15 End: 01/04/18 Due: 01/04/19

Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02826681 Org: User:
Start: 07/10/17 End: 07/01/22 Due: 07/01/23

Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)

Phase: N/A Priority: Normal
NCT ID: NCT01151592 Org: User:
Start: - End: - Due: -

Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN

Phase: N/A Priority: Normal
NCT ID: NCT05677126 Org: User:
Start: 08/31/24 End: 08/26/24 Due: 08/26/25

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00704028 Org: User:
Start: 06/30/08 End: 03/31/11 Due: 03/31/12

Safety and Efficacy of Iron Sucrose in Children

Phase: N/A Priority: Normal
NCT ID: NCT00239642 Org: User:
Start: 07/31/05 End: 04/30/10 Due: 04/30/11

Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS

Phase: N/A Priority: Normal
NCT ID: NCT02397057 Org: User:
Start: 01/31/15 End: 01/31/18 Due: 01/31/19

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT00721188 Org: User:
Start: 01/31/06 End: 01/31/10 Due: 01/31/11

Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT01307007 Org: User:
Start: 09/30/10 End: 08/31/13 Due: 08/31/14

Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA

Phase: N/A Priority: Normal
NCT ID: NCT03523117 Org: User:
Start: 01/31/19 End: 01/29/21 Due: 01/29/22

Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients

Phase: N/A Priority: Normal
NCT ID: NCT00548860 Org: User:
Start: 10/31/07 End: 07/31/09 Due: 07/31/10

Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy

Phase: N/A Priority: Normal
NCT ID: NCT02527213 Org: User:
Start: 01/30/15 End: 08/29/16 Due: 08/29/17

Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients

Phase: N/A Priority: Normal
NCT ID: NCT00354484 Org: User:
Start: 05/31/06 End: 01/31/07 Due: 01/31/08

Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT00236938 Org: User:
Start: 07/31/02 End: 10/31/04 Due: 10/31/05

Taxoprexin Treatment for Advanced Skin Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00249262 Org: User:
Start: 10/31/05 End: 04/30/07 Due: 04/30/08

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00087776 Org: User:
Start: 10/31/02 End: - Due: -

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00317239 Org: User:
Start: 05/31/05 End: 08/31/07 Due: 08/31/08

Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02478281 Org: User:
Start: 10/31/12 End: 03/31/13 Due: 03/31/14

Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women

Phase: N/A Priority: Normal
NCT ID: NCT01290315 Org: User:
Start: 08/31/09 End: 08/31/13 Due: 08/31/14